Difference-in-Difference (DID) estimators are a valuable method for identifying causal effects in the public health researcher's toolkit. A growing methods literature points out potential problems with DID estimators when treatment is staggered in adoption and varies with time. Despite this, no...

Financing retirement -- Were they prepared for retirement? : financial status at advanced ages in the HRS and AHEAD cohorts / James M. Poterba, Steven F. Venti, and David A. Wise ; comment, David Laibson -- Economic preparation for retirement / Michael D. Hurd and Susann Rohwedder ; comment,...

Using micro data on virtually all of the drugs and diseases of over 500,000 people enrolled in Puerto Rico's Medicaid program, we examine the impact of the vintage (original FDA approval year) of drugs used to treat a patient on the patient's 3-year probability of survival, controlling for...

The health sector is filled with institutions and decision-making circumstances that create friction in markets and cognitive errors by decision makers. This paper examines the potential contributions to health economics of the ideas of behavioral economics. The discussion presented here focuses...

The program project Early Indicators of Later Work Levels, Disease and Death investigates how socioeconomic and environmental factors in early life can shape health and work levels in later life. Project researchers have approached this problem by creating a life-cycle sample that permits a...

Improved health in low-income countries could considerably improve wellbeing and possibly promote economic growth. The last decade has seen a surge in field experiments designed to understand the barriers that households and governments face in investing in health and how these barriers can be...

We provide a theoretical and empirical analysis of the link between financial and real health care markets. This link is important as financial returns drive investment in medical research and development (R&D), which in turn, affects real spending growth. We document a "medical innovation...

The US health care sector is large and growing - health care spending in 2011 amounted to $2.7 trillion and 18% of GDP. Approximately half of health care output is allocated via markets. In this paper, we analyze the industrial organization literature on health care markets focusing on the...